Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
21/08/2026 02:46
BRIEF-Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges Aug 21 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
ISLAND BOOSTS GALIDESIVIR SUPPLY AS EBOLA SURGES
ISLANDPHARMACEUTICALS - ADDITIONAL PRODUCTION OF GMP-GRADE GALIDESIVIR COMMISSIONED WITH PI HEALTH SCIENCES
ISLND PHARMACEUTICALS LTD - GALIDESIVIR EXPECTED TO BE DEPLOYED IN UGANDA DURING CY26
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic